Stay ahead of regulatory changes with this targeted training on the DEA and HHS’s Fourth Temporary Extension for telemedicine prescribing of controlled substances. Learn the specific compliance steps, practitioner obligations, and technology standards needed to prescribe Schedules II-V medications remotely through December 31, 2026. Gain clarity on the interaction with other DEA/HHS rules and the enforcement risks of non-compliance. Ensure uninterrupted patient care and avoid costly penalties during this critical regulatory transition.
In this course you will learn the following:
* Understand the background and legal authority for the temporary extension of telemedicine flexibilities.
* Identify the specific requirements and conditions for prescribing controlled substances via telemedicine under the Fourth Temporary Rule.
* Implement actionable steps to ensure compliance with the rule’s requirements and deadlines.
* Recognize the interaction between this temporary rule and other related DEA/HHS rules.
* Understand the legal and financial consequences of non-compliance.
